Social Clips

7 Common Questions About Ofev

Ofev (nintedanib) is a treatment used for patients with idiopathic pulmonary fibrosis (IPF).  It is an anti-fibrotic drug that was approved by the FDA in October 2014 to help slow down the progression of the disease. Here are some of the most frequently asked questions about Ofev from the manufacturers, Boehringer Ingelheim. How…

5 Tips to Help Prevent Lung Infections

Pulmonary fibrosis (PF) patients are susceptible to lung infections which can often lead to hospitalization. According to the American Lung Association, there are several things you can do to help prevent lung infections. Practice Good Hygiene Regularly washing hands with soap and water — particularly before eating…

Pulmonary Fibrosis Symptoms: Weight Loss

Pulmonary fibrosis (PF) is a progressive chronic lung disease where the tissue in the lungs becomes scarred and stiffens. This can lead to a multitude of symptoms including breathlessness, persistent coughing, fatigue, joint pain and for some patients, weight loss. Pulmonary fibrosis symptoms: Aching joints and muscles Weight loss…

What You Need to Know About Ofev

Ofev (nintedanib) is a drug used in the treatment of idiopathic pulmonary fibrosis (IPF). The anti-fibrotic therapy is made by the pharmaceutical company Boehringer Ingelheim and was approved by the FDA in October 2014 and by the European Commission in January 2015. MORE: New knowledge about Ofev and Esbriet may…

Your PF Community

Woman laying down reading

Visit the Pulmonary Fibrosis News forums to connect with others in the PF community.

View Forums